ArticleCancers2020

Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.

Alessandro Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.